Market Place
Sourcing Support
All News #Library
Biotech
Prelude Therapeutics Presents PRT13722 Data at 2026 AACR Meeting
20 Apr 2026 //
GLOBENEWSWIRE
Prelude Announces Acceptance of Preclinical Abstract for PRT13722
17 Mar 2026 //
GLOBENEWSWIRE
Prelude Pharma Reveals 2025 Financials, 2026 Program Outlook
10 Mar 2026 //
GLOBENEWSWIRE
Prelude Gets IND Clearance for Mutant-Selective JAK2 Inhibitor
03 Feb 2026 //
GLOBENEWSWIRE
Prelude Therapeutics Unveils Myeloproliferative Neoplasm Data
06 Dec 2025 //
GLOBENEWSWIRE
Prelude Therapeutics Unveils Q3 Financials & Corporate Update
12 Nov 2025 //
GLOBENEWSWIRE
Prelude Loses CMO, Pauses SMARCA2 Degraders, Scores Incyte Cash
04 Nov 2025 //
FIERCE BIOTECH
Prelude Therapeutics To Present Abstracts at ASH Meeting
03 Nov 2025 //
GLOBENEWSWIRE
Prelude Calls It Curtains on Lead SMARCA2 Cancer Asset
14 Aug 2025 //
FIERCE PHARMA
Pathos AI`s $365M series D to fund trial of Novo tumor drug
15 May 2025 //
FIERCE BIOTECH
Prelude Therapeutics Reports Q1 2025 Results and Update
06 May 2025 //
GLOBENEWSWIRE
Prelude Therapeutics Presents Phase 1 Results of PRT2527 Study
11 Dec 2024 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.